Related Experiment Videos
Inhibitor of Pancreatic Cancer by RHIL1RA-Letter
Sinan Lu1, Shusen Zheng2,3, Weilin Wang2,3,4
1Key Lab of Combined Multi-Organ Transplantation, Ministry of Public Health, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pancreas preservation time as a predictor of prolonged hospital stay after pancreas transplantation.
The Journal of international medical research·2021
AG-1024 Sensitizes Sorafenib-Resistant Hepatocellular Carcinoma Cells to Sorafenib via Enhancing G1/S Arrest.
OncoTargets and therapy·2021
Recipient gender and body mass index are associated with early acute rejection in donation after cardiac death liver transplantation.
Clinics and research in hepatology and gastroenterology·2021
Severity of early allograft dysfunction following donation after circulatory death liver transplantation: a multicentre study.
Hepatobiliary surgery and nutrition·2021
HexaBody-OX40 promotes antitumor immunity through FcγR crosslinking-independent OX40 agonist activity and enhances effects of PD-1 blocking antibodies.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Carboplatin Plus Mirvetuximab Soravtansine In Platinum-Sensitive Ovarian Cancer: A Phase 2 Nonrandomized Clinical Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Serial circulating tumour DNA monitoring in first-line advanced NSCLC (COPE): a randomized, two-arm non-comparative phase II trial.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
DuoBody®-FAPαxDR4 is a novel DR4 agonist that induces potent antitumor activity through FAPα-dependent, DR4-transactivation-mediated apoptosis.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Long-Term Outcomes and Biomarker Correlates of a Multi-Institutional Phase II Study of Hypofractionated Proton Beam Therapy for Unresectable Primary Liver Tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
When the Tumor Disappears, Must the Larynx Follow?
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Advanced Therapies for Diabetic Kidney Disease: A Critical Review of Gene-, RNA-, and Cell-Based Strategies to Address Residual Risk.
Diseases (Basel, Switzerland)·2026
Association of DNA Copy Number Aberrations with Organ-Specific Metastasis in Luminal B HER2-Negative Breast Cancer.
Diseases (Basel, Switzerland)·2026